More research has demonstrated that the expression of EGFRvIII induces the transactivation of c-Jun N-terminal kinase isoform 2 (JNK2) in GBM cells, which, in turn, activates the hepatocyte growth factor (HGF)/c-MET signalling pathway [73]. The gene discussed is HGF; the disease is glioblastoma.